Audience-specific positioning and reviewed product communication for life-sciences and medical-technology businesses.
Takes 2 minutes · No signup to start · Get a free downloadable PDF report
Life-sciences business marketing should not start with “how many posts?”
It should start with what people need to understand — and what your teams need to manage.
An independent concept for evidence-led medtech communication: restrained identity, specification hierarchy and routes to approved documentation for professional buyers.
Inspect the concept briefLabels match the work page: the internal record shows our own delivered website; concepts are independent fictional scenarios, not client projects. Commissioned client evidence appears here only with permission.
These are common situations to assess, not assumptions about every life-sciences business. BrandlyUp can improve communication systems; operational and clinical decisions stay with your team.
Different professional audiences need different levels of detail.
Approved information needs a visible source and review process.
Professional buyers need clear scope and next steps.
Three connected disciplines — branding, marketing and reputation — shaped around your life-sciences business, not around a posting calendar.
Define audience-specific positioning and scientific communication standards.
Professionals and procurement teams can find information written for their needs.
Create reviewed product explainers, technical resources and enquiry content.
Qualified audiences can locate the material needed for a focused discussion.
Build claim-to-source content structures and a clear review workflow.
Readers can distinguish approved information from unsupported assertions.
Instead of vague claims, here is a representative structure for a life-sciences business engagement — illustrative and proposed for your brief, not a client result or a live account.
| Work area | What you receive | How it is measured |
|---|---|---|
| Position for the appropriate audience |
| Professional enquiries |
| Make reviewed information easier to use |
| Content review completion |
| Guide professional evaluation |
| Evaluation progression |
A proposed measurement plan. Targets follow your baseline and the data you can provide.
Appropriate business requests matching the defined audience.
CountRequired content records with documented approval.
PercentageQualified professional enquiries advancing to the next stage.
PercentageA sample planning scope for this sector, with the inputs and approvals a project needs.
Phases and timings are sample planning scopes, not committed schedules. The agreed plan, review cadence and fees follow discovery.
Compare engagement modelsEvery engagement includes a shared workspace for deliverables, approvals and reporting — plus free self-checks you can use right now, before you talk to anyone.
Hold product information, evidence references and approval workflows in one shared workspace, with authorised reviewer sign-off before release.
Review evidence, policies and accountability.
No account needed · FreeOpen in ToolsReview audience, offer and differentiation.
No account needed · FreeOpen in ToolsChoose essential and optional scope; download your editable draft.
No account needed · FreeStart on this pageThe dashboard is included with your engagement — it is not sold as standalone software. Previews show a representative sample, not your live data. Self-checks are free, need no account and do not scan your website or assign a score.
Six practical questions about your current communication. Questions for your selected challenge appear first. Answer from what you know; “Not sure” is a useful answer. This does not scan your website.
1. Is each product's intended professional audience clear?
2. Is intended use distinguished from unsupported or off-label claims?
3. Can distributors or clinicians find the technical documents they need?
4. Does a professional enquiry collect application context without patient data?
5. Can every published performance claim be traced to approved evidence?
6. Is an authorised reviewer responsible for updates, limitations and product information?
Audience framework · Positioning document · Message hierarchy
Product-information pages · Evidence references · Approval workflow
Professional enquiry design · Evaluation guide · Capability presentation
DRAFT PROJECT BRIEF — human review required Industry: Pharma & Medtech Business type: Medical devices Website: Not sure / not provided Assessment: Not completed (industry-readiness-v2; self-assessment, not a website audit) Inputs: current materials, business goals, audience questions and approved evidence. Exclusions: advertising/media costs, third-party subscriptions, guarantees and regulated advice. Measurement: Professional enquiries; Content review completion; Evaluation progression. Baselines agreed at review. Approvals: client sign-off for facts, claims, creative and launch. Pricing pending review. Your priorities: To discuss Next: review scope with BrandlyUp; agree responsibilities, timing and price before work starts.
Inputs, exclusions, approvals and measurement are included in the draft. Review it above any time — nothing is sent. Answers and notes stay in this page’s memory only; chosen service IDs are kept in this tab for up to 24 hours so you can return to your plan.
Share your name and email — we’ll send a formatted PDF copy of this brief and follow up on next steps.
A working concept for how branding, marketing and reputation could look — not a finished design, a live client project or a claim about results.
Give clinicians, buyers and channel partners a clear reason to evaluate your offer.
Product architecture, technical messaging and portfolio materials.
Audience-specific product pages and distributor enquiry journeys.
Traceable claims, approved evidence and current product documentation.
Professional enquiries · Content review completion · Evaluation progression
Proposed scope, tailored after discovery. Outcomes depend on your starting point and execution.Foundation packages are one-time implementation projects. Monthly packages are ongoing alternatives — not cumulative purchases on top of a foundation. Final fees follow an agreed scope after discovery.
One-time implementation: identity, information and enquiry handling organised.
Request a scoped quote
A consistent identity and organised information foundation.
Taxes, advertising spend, hosting, third-party subscriptions, onsite production, printing and major integrations are quoted separately.
Ongoing communication, information accuracy and review governance.
Request a scoped quote
Current information and consistent communication.
Taxes, advertising spend, hosting, third-party subscriptions, onsite production, printing and major integrations are quoted separately.
Central governance for multi-location or multi-audience operations.
Request a scoped quote
Consistent communication with clear ownership of ongoing work.
Taxes, advertising spend, hosting, third-party subscriptions, onsite production, printing and major integrations are quoted separately.
Pharma Foundation sets up identity, information and enquiry handling once. Pharma Visibility & Communication and Pharma Communication Partner keep that work current — choose one ongoing level, not both. If your website and materials already work, start from the maintenance level rather than a rebuild. Not sure which level fits? Compare engagement models.
Package scope examples for this industry. Draft pricing is pending internal approval and is not shown publicly.
Useful answers, specific examples and checklists you can apply to your business.
Pharma and medtech communication should use controlled, approved product information and clear responsibility for review.
Read the guide →: Pharma and medtech communication with approved product factsA working site with its own identity, pages, enquiry journey and Hindi edition. Use it to judge the direction before we tailor one to your business.
Brand systems, approved product information and B2B communication for pharma and medtech teams.
Start with one priority, or combine disciplines in an agreed scope. These are example deliverables, not a package that every business needs.
Discuss your business, priority and available materials. If the work is a fit, agree scope, deliverables, review responsibilities, fees and timing before starting. No fixed turnaround or free audit is implied.
Compare engagement options.
Your current website and brand assets, approved information about your offer, the audience you want to reach, one decision owner and suitable reviewers. Appropriate medical, regulatory and legal reviewers must approve content. This is not patient appointment marketing or a compliance certification.
The focus is brand, marketing and reputation communication. Booking engines, payments, CRM replacement and operating software are separate technical projects. Any integration work must be scoped explicitly.
No. We can define the work, improve communication and agree a measurement plan. Sales also depend on your offer, pricing, demand, traffic quality and follow-up. Baselines and targets are agreed using your available data.
The industry photographs show representative businesses, people and working environments. They are stock photography, not BrandlyUp client projects or endorsements. Our proposed scope is tailored to your brief; the work page identifies actual work and concepts.
Fees are proposed after a short discovery, because scope varies with locations, products or services, languages, channels and approval complexity. The pricing page explains the engagement models and what is included; we do not quote invented starting prices here.
Yes. The engagement is scoped around named deliverables and review owners, so your agency or team can keep the channels they run. At discovery we agree who produces, who reviews and who publishes, to avoid duplicated work.
Our scope is professional and distributor communication — evidence pages, evaluation material, trade content — within your regulatory reviewers’ approval. Patient-facing promotion is a regulated activity we do not take on.
Choose your priority and tell us what needs to change. Your pharma & medtech brief stays right here.
Appropriate medical, regulatory and legal reviewers must approve content. This is not patient appointment marketing or a compliance certification.
Deliverables and targets are agreed in discovery. These are proposed approaches and illustrative images, not achieved client results. Booking, CRM and other integrations need a separately agreed technical scope.
